1. Home
  2. PRKS vs STOK Comparison

PRKS vs STOK Comparison

Compare PRKS & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Parks & Resorts Inc.

PRKS

United Parks & Resorts Inc.

HOLD

Current Price

$47.04

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.37

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRKS
STOK
Founded
1959
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
PRKS
STOK
Price
$47.04
$31.37
Analyst Decision
Buy
Strong Buy
Analyst Count
10
10
Target Price
$47.50
$39.20
AVG Volume (30 Days)
930.2K
541.4K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.73
EPS
N/A
N/A
Revenue
$1,263,324,000.00
$184,420,000.00
Revenue This Year
$3.45
N/A
Revenue Next Year
$3.08
$77.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
404.50
52 Week Low
$28.77
$11.17
52 Week High
$56.95
$40.22

Technical Indicators

Market Signals
Indicator
PRKS
STOK
Relative Strength Index (RSI) 69.86 52.75
Support Level $33.89 $30.34
Resistance Level $56.33 $35.11
Average True Range (ATR) 1.94 1.46
MACD 0.37 0.24
Stochastic Oscillator 81.96 83.58

Price Performance

Historical Comparison
PRKS
STOK

About PRKS United Parks & Resorts Inc.

United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: